Crossref
journal-article
Elsevier BV
Blood Cells, Molecules, and Diseases (78)
References
22
Referenced
83
10.7326/0003-4819-118-3-199302010-00003
/ Ann. Intern. Med. / Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant by Goodrich (1993)10.1182/blood.V86.7.2815.2815
/ Blood / Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation by Einsele (1995)10.1182/blood.V78.5.1373.1373
/ Blood / Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease by Reusser (1991)10.1182/blood.V83.7.1971.1971
/ Blood / Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis by Li (1994)10.1128/JVI.55.2.264-273.1985
/ J. Virol. / Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs by Reddehase (1985)10.1056/NEJM199404283301703
/ N. Engl. J. Med. / Infusions of donor leukocytes to treat Epstein–Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation by Papadopoulos (1994)10.1182/blood.V68.3.770.770
/ Blood / Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease by Kernan (1986)10.1111/j.1749-6632.1991.tb33450.x
/ Ann. N.Y. Acad. Sci. / Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro by Greenberg (1991)10.1126/science.1352912
/ Science / Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones by Riddell (1992)10.1038/nm0596-551
/ Nat. Med. / Long-term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes by Heslop (1996)10.1182/blood.V97.4.994
/ Blood / Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions by Peggs (2001)10.1182/blood.V99.1.213
/ Blood / Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells by Peggs (2002)10.1046/j.1365-2141.2000.02419.x
/ Br. J. Haematol. / Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation by Peggs (2000)10.1097/00007890-200106150-00021
/ Transplantation / Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients by Guiver (2001)10.1126/science.274.5284.94
/ Science / Phenotypic analysis of antigen-specific T lymphocytes by Altman (1996)10.1128/JVI.70.11.7569-7579.1996
/ J. Virol. / The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL by Wills (1996)10.1086/340637
/ J. Infect. Dis. / Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals by Kern (2002)10.1086/339963
/ J. Infect. Dis. / Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype by Khan (2002)10.1182/blood.V99.3.1071
/ Blood / Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen by Chakraverty (2002)10.1182/blood.V97.5.1232
/ Blood / Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation by Cwynarski (2001)10.1086/323354
/ J. Infect. Dis. / Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants by Aubert (2001)10.1182/blood.V98.5.1358
/ Blood / Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection by Gratama (2001)
Dates
Type | When |
---|---|
Created | 17 years, 11 months ago (Sept. 17, 2007, 8:21 a.m.) |
Deposited | 5 years, 4 months ago (April 26, 2020, 10:36 a.m.) |
Indexed | 4 days, 7 hours ago (Aug. 28, 2025, 8:37 a.m.) |
Issued | 17 years, 8 months ago (Jan. 1, 2008) |
Published | 17 years, 8 months ago (Jan. 1, 2008) |
Published Print | 17 years, 8 months ago (Jan. 1, 2008) |
@article{Mackinnon_2008, title={Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells}, volume={40}, ISSN={1079-9796}, url={http://dx.doi.org/10.1016/j.bcmd.2007.07.003}, DOI={10.1016/j.bcmd.2007.07.003}, number={1}, journal={Blood Cells, Molecules, and Diseases}, publisher={Elsevier BV}, author={Mackinnon, Stephen and Thomson, Kirsty and Verfuerth, Stephanie and Peggs, Karl and Lowdell, Mark}, year={2008}, month=jan, pages={63–67} }